Camden Capital »

Biogen Idec shares owned by Camden Capital

Quarter-by-quarter ownership of Biogen Idec (BIIB) shares owned by Camden Capital from 13F filings

Historical chart of Camden Capital investment in Biogen Idec

Tip: Access up to 7 years of quarterly data

All positions including Biogen Idec held by Camden Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biogen Idec by Camden Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $245k 947 258.77
2023-09-30 $233k 915 255.00
2023-06-30 $253k 897 281.87
2021-06-30 $222k 642 345.79